Biotech

All Articles

Capricor shares extra information for DMD therapy after starting BLA

.Capricor Therapies is taking a triumph tour for their stage 2 Duchenne muscular dystrophy (DMD) tri...

FDA locations Kezar lupus trial in hold observing 4 person deaths

.The FDA has actually positioned Kezar Lifestyle Sciences' lupus trial on grip after the biotech war...

Phase 3 Scholar Rock trial hits SMA objective, sending stock up 200%

.A period 3 trial of Scholar Stone's back muscular atrophy (SMA) candidate has actually struck its k...

CAMP 4 is latest to eye IPO, while Upstream point out $182M program

.RNA biotech CAMP4 Therapies has actually defined think about a $67 thousand IPO, along with inflamm...

Galecto gets leukemia medicine, goes down bone tissue cancer cells resource in pivot

.A year after the failing of an idiopathic lung fibrosis prospect delivered Galecto on a hunt for re...

Judo throws down $100M to knock senseless renal illness

.Taking the floor covering is Judo Biography, a promising biotech equipped along with $100 million t...

AstraZeneca pays out CSPC $100M for preclinical heart disease medicine

.AstraZeneca has actually paid CSPC Pharmaceutical Group $one hundred thousand for a preclinical hea...

Zephyrm looks for Hong Kong IPO to money period 3 tissue therapy trials

.Zephyrm Bioscience is gusting toward the Hong Kong stock market, submitting (PDF) for an IPO to sta...

Frazier Life Sciences gathers $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced an additionally $630 thousand for its fund concentra...

GigaGen gathers around $135M BARDA bucks to beat botox

.Antibody connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its...